metreleptin

2 FDA Decisions You Need to Watch Next Week
Motley Fool
Fri, 02/21/14 - 05:12 pm
FDA
metreleptin
Bristol-Myers Squibb
lipodystrophy
AstraZeneca
hypogonadism
Endo Health Solutions
Aveed
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Fierce Biotech
Thu, 12/12/13 - 04:15 pm
FDA
advisory panels
Bristol-Myers Squibb
metreleptin
AstraZeneca
partial lipodystrophy
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
Bristol drug for fat disorder may work, but risky - FDA staff
Reuters
Tue, 12/10/13 - 09:46 am
Bristol-Myers Squibb
FDA
metreleptin
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
Bristol-Myers Squibb and AstraZeneca say FDA will speed up review of lipid disorder drug
Yahoo/AP
Wed, 06/5/13 - 10:05 am
FDA
Bristol-Myers Squibb
metreleptin
AstraZeneca
Amylin completes application to FDA for metreleptin
Yahoo/Fly on the Wall
Tue, 04/3/12 - 10:10 am
FDA
metreleptin
Amylin
lipodystrophy
Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs?
Seeking Alpha
Mon, 03/19/12 - 10:47 am
Roche
obesity
Amylin
diabetes
Xenical
Orlistat
metreleptin
Alli
Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy
Yahoo/PR NewsWire
Sun, 06/5/11 - 09:58 am
metreleptin
diabetes
partial lipodystrophy
Amylin
Taking a Bite Out of Amylin's Obesity Drug Potential
Motley Fool
Thu, 03/17/11 - 11:29 pm
Amylin
obesity
pramlintide
metreleptin
Takeda
Amylin, Takeda Suspend Clinical Activities in Obesity Trial
Bloomberg
Wed, 03/16/11 - 11:59 am
obesity
Amylin
Takeda
pramlintide
metreleptin